
Hematologist/Oncologist, BMT/Cell therapy @kucancercenter. interests-too many,here for articles related to intersection of science & society. views my own.
Kansas City,KS
Joined April 2009
- Tweets1.3K
- Following816
- Followers1.2K
- Likes2.7K
Pinned Tweet
We have come a long way from Coley's toxins to CRISPR CARs. For those who are fascinated by history. @KUcancercenter
Historical Review: #CARTcells: continuation in a revolution of #immunotherapy thelancet.com/journals/lanon…
The whole mission will have to be aborted if they tried to login to EPIC EMR.
#NEWS 🚨: Artemis II crew experienced issues with Outlook this morning and had to ask ground crew for assistance
"We have two Microsoft Outlooks and neither one is working"
2
221
Anurag Singh retweeted
Memorizing random facts for ABIM board MOC has always been a waste of time. In the era of AI it is just ridiculous. Only justification is to extract time and money from practicing physicians.
If you read one thing this Saturday, read @anish_koka 's thoughtful commentary about the whole mess at FDA and why departure of @VPrasadMDMPH should worry anyone who cares about runaway costs of marginal drugs.
1
1
162
Anurag Singh retweeted
Nothing beats good science, great colleagues, and time together. Team dinner with the University of Kansas Medical Center Transplant & Cellular Therapy team at the 2026 Tandem Meetings (ASTCT & CIBMTR) in Salt Lake City, UT. @aksinghmd @KUcancercenter
#TandemMeetings #CellTherapy #Transplant #KUMed
Anurag Singh retweeted
Honored to share our first‑author publication in @BloodJournal on a phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy for relapsed/refractory AML after allogeneic HCT: feasible manufacturing, acceptable safety, and early signals of activity in a very high‑risk population.
@KUcancercenter @VorBio
doi.org/10.1182/blood.202503…
#AML #CARTcells #AlloHCT #Hematology
Abstracts from the 2026 Tandem Meetings have been published in a special supplement of Transplantation and Cellular Therapy. Review the supplement now: ow.ly/ogln50Y8pip
Anurag Singh retweeted
At the ASH Review in Kansas, learning cutting-edge updates in #MultipleMyeloma from Dr. Sagar @SagarLonialMD —exciting advances in immunotherapy, sequencing, and real-world care. The future for our patients keeps getting brighter. 🔬
#MedEd #MedTwitter #mmsm #myeloma #USMIRC @USMIRCNEWS @Larvol @oncodaily
Anurag Singh retweeted
If the ACGME cared about residents, they would mandate programs report electronic health record time. Programs that forced residents to spend too much time on the computer would be cited. This would force hospitals to hire more APPs or optimize their EHRs or both.
Anurag Singh retweeted
Said a different way, have you ever done a mandatory module and thought, "wow that was very helpful and not a waste of my time." ?
Great points . I would also add
-don’t tweet/retweet to get on some random #ASH25 social media leaderboard . They mean nothing and it spams the feed of those unable to attend and following it on social media.
-celebrate progress but don’t be afraid of pointing out serious flaws with a trial/drug
For #ASH25 attendees
I’ve been on this platform for 16 years. Here are some tips on how to be productive, and gain influence and credibility on X.
1) Highlight new information, but also give your take on it as well. Thats what makes the content interesting.
2) Be active almost on a daily basis. This is important.
3) Writing is an art; writing on Twitter more so. Being simple and succinct is not easy. Keep at it.
4) Post some pics and some fun non-medical stuff now and then. You need to show your personality.
5) Only retweet content that you endorse. My retweets are always endorsements. (A like is like a mild retweet)
6) Use bookmarks for saving tweet to be read in the future. Don’t use the like button for this purpose. (I’m still struggling to comply with this! Old habits)
7) Critique, but don’t make your posts all negative. Be balanced.
Assume positive intent. Your colleagues are also trying to do the right thing. It’s not easy to do the perfect study.
8) Avoid personal attacks at all costs
9) Don’t reply or engage with anyone who goes after you or attacks you. Engaging is amplifying. It’s not worth it.
10) Mute accounts that cause you distress. Liberally. You want to have a peaceful life. Block accounts if it’s really bothering you.
11) Engage with friends and colleagues with replies. Reply to those who reply to your tweet if possible.
12) Toggle your timeline to “Following” not “For You” to make sure you see content from people you follow and not random stuff. There’s a lot of it on here.
13) While it’s ok to give your general take on a particular medical condition, avoid providing direct medical advice on here. I can elaborate more on how to approach this very frequent situation on here.
14) Be kind and respectful. It’s very tempting to be snarky at times. Resist the urge. It’s in writing and permanent, so not worth it.
15)Follow the right people.
16) Posting content with pics or videos creates more engagement than text alone.
17) Make it clear on your profile that these are solely your personal opinions, unless you are posting in official or institutional capacity.
18) Have fun
When used well, Twitter is an incredible platform for medicine. To learn and disseminate content, keep up to date, connect with colleagues, make new friends with people in diverse fields, and more.
7
695
Anurag Singh retweeted
🔑 for those discussing or presenting results at @ASH_hematology! This also applies to us TWEETING about results #ASH25
- Present a balanced appraisal - remember, we are caregivers and scientists, not cheerleaders
- do not minimize toxicities or QOL!
sciencedirect.com/science/ar…
Agree. I will also add that autologous transplants are wayyyy safer than currently available CAR-T constructs with a predictable side effect profile . That might change with future CAR-T constructs but until then autologous transplants can safely improve PFS and help delay CAR-T and associated toxicities.
Only discussion to make sense of what is really important in Myeloma and what really matters to the patients.
This Thanksgiving, we're thankful for the Myeloma Man Manni Mohyuddin, who came on the podcast to discuss the key #ASH25 abstracts in multiple myeloma, including the results of the #MajesTEC-3 trial! Cheers! 🍻🙏🦃 @Berninini @ajperissinotti @ManniMD1 open.spotify.com/episode/4uI…
Aaron is right . The unsustainable cost of health care is a complex, multifaceted problem, and much of it lies beyond the control of individual physicians. However, physicians and their professional societies can be more cautious about endorsing marginal drugs that add significant financial burden without meaningful benefit. If a drug can truly cure or transform outcomes, society may reasonably bear the cost. But many new drugs simply lower a lab value or slightly improve a scan for a few months, often on the basis of weak evidence. Their manufacturers then recruit key opinion leaders (KOLs) to wax poetic about them at sponsored events, celebrating 'another option'.
Anurag Singh retweeted
The IMWG needs discourse. Invite physicians to join like @rajshekharucms and @ManniMD1 Otherwise just one big echo chamber where we will soon treat healthy people with daratumumab to prevent progression to MGUS.
Why should this surprise anyone When you make betting as easy as sending a text message!!
nytimes.com/live/2025/10/23/…
173

























